OVP offers anti-COVID-19 drug treatment | Inquirer News

OVP offers anti-COVID-19 drug treatment

/ 05:10 AM January 08, 2022

(Photo by Jay Ganzon / OVP)

People infected with COVID-19 can get access to the drug molnupiravir through the Office of the Vice President’s (OVP) e-Konsulta program, Vice President Leni Robredo assured the public on Friday amid fears that medicine may be in short supply as cases reach new record highs.

In a video message, Robredo said her office’s main programs—the Bayanihan e-Konsulta program (for free online consultations for outpatient needs) and the Swab Cab initiative (free mobile antigen testing in high-risk areas) are still in full swing.

Article continues after this advertisement

She added that qualified patients who need molnupiravir can message the Bayanihan e-Konsulta page on Facebook and would be referred by the volunteer doctors to the program’s partner hospitals.

“This is free and this will be sent to your homes,” Robredo assured. —Krixia Subingsubing

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Leni Robredo, OVP

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.